🔗 Share this article

This year's prestigious award in medical science has been granted for transformative findings that clarify how the immune system targets dangerous infections while sparing the body's own cells.

A trio of renowned researchers—from Japan Shimon Sakaguchi and US experts Dr. Brunkow and Fred Ramsdell—received this accolade.

Their work uncovered unique "sentinels" within the immune system that remove rogue immune cells that could attacking the body.

The discoveries are now paving the way for innovative treatments for autoimmune diseases and cancer.

These winners will divide a monetary award worth 11 million SEK.

Decisive Findings

"The research has been decisive for understanding how the immune system operates and why we don't all develop severe self-attack conditions," commented the head of the award panel.

The team's research explain a fundamental question: In what way does the immune system protect us from numerous invaders while leaving our own tissues intact?

The body's protection system uses white blood cells that search for signs of disease, including pathogens and bacteria it has never encountered.

Such cells utilize sensors—known as recognition units—that are produced by chance in countless variations.

That gives the defense network the capacity to fight a broad range of invaders, but the randomness of the process inevitably produces white blood cells that can attack the host.

Protectors of the Immune System

Researchers earlier understood that a portion of these problematic white blood cells were eliminated in the immune organ—where white blood cells develop.

The latest Nobel Prize recognizes the identification of T-reg cells—described as the immune system's "security guards"—which travel through the body to disarm any defenders that attack the body's own tissues.

We know that this process malfunctions in autoimmune diseases such as type-1 diabetes, multiple sclerosis, and RA.

The prize committee added, "The findings have established a new field of investigation and accelerated the development of innovative therapies, for instance for tumors and immune disorders."

Regarding malignancies, T-regs prevent the system from fighting the growth, so studies are focused on lowering their quantity.

For self-attack disorders, experiments are testing boosting T-reg cells so the organism is not under attack. A comparable approach could also be effective in reducing the chances of transplanted organ rejection.

Pioneering Studies

Prof Sakaguchi, from Osaka University, conducted experiments on rodents that had their thymus extracted, causing autoimmune disease.

The researcher showed that introducing immune cells from healthy mice could stop the disease—implying there was a mechanism for preventing immune cells from attacking the host.

Mary Brunkow, affiliated with the a research center in Seattle, and Dr. Ramsdell, currently at Sonoma Biotherapeutics in San Francisco, were investigating an inherited autoimmune disease in rodents and humans that led to the identification of a genetic factor critical for the way T-regs function.

"Their pioneering research has revealed how the immune system is controlled by regulatory T cells, stopping it from mistakenly attacking the body's own tissues," said a leading physiology expert.

"The work is a striking illustration of how basic biological research can have far-reaching consequences for human health."